Home
MIST
MIST News

Latest Milestone Pharmaceuticals Inc. (MIST) News on November 15, 2024

Associated Press Finance

3 days ago

Milestone Pharmaceuticals: Q3 Earnings Snapshot

Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update

GlobeNewswire

3 days ago

Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update

Individual investors account for 54% of Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) ownership, while institutions account for 46%

Simply Wall St.

a month ago

Individual investors account for 54% of Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) ownership, while institutions account for 46%

Milestone Pharmaceuticals to Host Investor KOL Event

GlobeNewswire

2 months ago

Milestone Pharmaceuticals to Host Investor KOL Event

MT Newswires

2 months ago

Milestone Pharmaceuticals' Partner Ji Xing's Phase 3 Trial of Etripamil Meets Primary Endpoint

Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China

GlobeNewswire

2 months ago

Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China

Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors

GlobeNewswire

2 months ago

Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors

Milestone® Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

2 months ago

Milestone® Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024

GlobeNewswire

3 months ago

Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024

Associated Press Finance

3 months ago

Milestone Pharmaceuticals: Q2 Earnings Snapshot

Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and Corporate Update

GlobeNewswire

3 months ago

Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and Corporate Update

Milestone® Pharmaceuticals to Present at the Upcoming BTIG Virtual Biotechnology Conference

GlobeNewswire

3 months ago

Milestone® Pharmaceuticals to Present at the Upcoming BTIG Virtual Biotechnology Conference

Milestone Pharmaceuticals Refreshes Board of Directors

GlobeNewswire

4 months ago

Milestone Pharmaceuticals Refreshes Board of Directors

Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024

GlobeNewswire

5 months ago

Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024

It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put Under The Microscope

Simply Wall St.

5 months ago

It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put Under The Microscope

Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference

GlobeNewswire

5 months ago

Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference

MT Newswires

6 months ago

Milestone Pharmaceuticals Says US FDA Accepts New Drug Application for Cardamyst Nasal Spray for Arrhythmia

Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™

GlobeNewswire

6 months ago

Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™

Milestone Pharmaceuticals Partners with Arrhythmia Alliance on SVT Awareness

GlobeNewswire

6 months ago

Milestone Pharmaceuticals Partners with Arrhythmia Alliance on SVT Awareness

Milestone Pharmaceuticals (MIST) Upgraded to Buy: Here's What You Should Know

Zacks

6 months ago

Milestone Pharmaceuticals (MIST) Upgraded to Buy: Here's What You Should Know

Associated Press Finance

6 months ago

Milestone Pharmaceuticals: Q1 Earnings Snapshot

Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update

GlobeNewswire

6 months ago

Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update

Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024

GlobeNewswire

6 months ago

Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024

Milestone® Pharmaceuticals to Present Data on Etripamil at the Preventative Cardiovascular Nursing Symposium

GlobeNewswire

7 months ago

Milestone® Pharmaceuticals to Present Data on Etripamil at the Preventative Cardiovascular Nursing Symposium

Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting

GlobeNewswire

7 months ago

Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting

Milestone® Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference

GlobeNewswire

7 months ago

Milestone® Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference

Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences

GlobeNewswire

7 months ago

Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences

Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia

GlobeNewswire

8 months ago

Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Regulatory and Corporate Update

GlobeNewswire

8 months ago

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Regulatory and Corporate Update

Milestone® Pharmaceuticals to Participate in a Corporate Panel Discussion at TD Cowen 44th Annual Health Care Conference

GlobeNewswire

9 months ago

Milestone® Pharmaceuticals to Participate in a Corporate Panel Discussion at TD Cowen 44th Annual Health Care Conference

Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants

GlobeNewswire

9 months ago

Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants

Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

GlobeNewswire

9 months ago

Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil for the Treatment of PSVT

GlobeNewswire

9 months ago

Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil for the Treatment of PSVT

aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity

GlobeNewswire

10 months ago

aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity

Primis Financial Corp. Reports Earnings per Share for the Fourth Quarter of 2023

PR Newswire

10 months ago

Primis Financial Corp. Reports Earnings per Share for the Fourth Quarter of 2023

HYZON DELIVERS FIRST FOUR FUEL CELL ELECTRIC VEHICLES TO PERFORMANCE FOOD GROUP

PR Newswire

10 months ago

HYZON DELIVERS FIRST FOUR FUEL CELL ELECTRIC VEHICLES TO PERFORMANCE FOOD GROUP

Here's Why We Think First National (NASDAQ:FXNC) Is Well Worth Watching

Simply Wall St.

10 months ago

Here's Why We Think First National (NASDAQ:FXNC) Is Well Worth Watching

Arbe Celebrates Milestone Achievements as Sensrad Announces Major Customer Orders for Revolutionary Radar Technology

GlobeNewswire

10 months ago

Arbe Celebrates Milestone Achievements as Sensrad Announces Major Customer Orders for Revolutionary Radar Technology

Down -43.64% in 4 Weeks, Here's Why Milestone Pharmaceuticals (MIST) Looks Ripe for a Turnaround

Zacks

10 months ago

Down -43.64% in 4 Weeks, Here's Why Milestone Pharmaceuticals (MIST) Looks Ripe for a Turnaround

It Might Not Be A Great Idea To Buy Luxfer Holdings PLC (NYSE:LXFR) For Its Next Dividend

Simply Wall St.

10 months ago

It Might Not Be A Great Idea To Buy Luxfer Holdings PLC (NYSE:LXFR) For Its Next Dividend

ACCESSWIRE

10 months ago

Monterey Capital Acquisition Corporation Announces Filing of Registration Statement on Form S-4 in Connection with Its Proposed Business Combination with ConnectM

SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting

PR Newswire

10 months ago

SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting

5 Stocks With Recent Price Strength to Grab Now

Zacks

10 months ago

5 Stocks With Recent Price Strength to Grab Now

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides Business Update

PR Newswire

10 months ago

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides Business Update

NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

News Direct

a year ago

NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Milestone Pharma (MIST) Down on Regulatory Update for Etripamil

Zacks

a year ago

Milestone Pharma (MIST) Down on Regulatory Update for Etripamil

Milestone Pharmaceuticals Receives Refusal to File Letter from U.S. FDA for New Drug Application for Etripamil in the Treatment of PSVT

GlobeNewswire

a year ago

Milestone Pharmaceuticals Receives Refusal to File Letter from U.S. FDA for New Drug Application for Etripamil in the Treatment of PSVT

Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) top owners are individual investors with 52% stake, while 34% is held by institutions

Simply Wall St.

a year ago

Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) top owners are individual investors with 52% stake, while 34% is held by institutions

Institutional investors may adopt severe steps after Telos Corporation's (NASDAQ:TLS) latest 11% drop adds to a year losses

Simply Wall St.

a year ago

Institutional investors may adopt severe steps after Telos Corporation's (NASDAQ:TLS) latest 11% drop adds to a year losses

3 Off-the-Beaten-Path Stocks Poised for Substantial Growth

InvestorPlace

a year ago

3 Off-the-Beaten-Path Stocks Poised for Substantial Growth

BEN Appoints Rick Howard as Chief Information and Data Officer

Business Wire

a year ago

BEN Appoints Rick Howard as Chief Information and Data Officer

Lifetime Brands' (NASDAQ:LCUT) Dividend Will Be $0.0425

Simply Wall St.

a year ago

Lifetime Brands' (NASDAQ:LCUT) Dividend Will Be $0.0425

Cohen & Steers Closed-End Funds Declare Distributions for January, February, and March 2024

PR Newswire

a year ago

Cohen & Steers Closed-End Funds Declare Distributions for January, February, and March 2024

Beat the Market the Zacks Way: Shopify, Lululemon, Telos in Focus

Zacks

a year ago

Beat the Market the Zacks Way: Shopify, Lululemon, Telos in Focus

Li-Cycle Comments on Process to Evaluate Financing and Strategic Alternatives

Business Wire

a year ago

Li-Cycle Comments on Process to Evaluate Financing and Strategic Alternatives

Investors in TETRA Technologies (NYSE:TTI) have seen incredible returns of 440% over the past three years

Simply Wall St.

a year ago

Investors in TETRA Technologies (NYSE:TTI) have seen incredible returns of 440% over the past three years

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

Should You Be Worried About Park-Ohio Holdings Corp.'s (NASDAQ:PKOH) 6.8% Return On Equity?

Simply Wall St.

a year ago

Should You Be Worried About Park-Ohio Holdings Corp.'s (NASDAQ:PKOH) 6.8% Return On Equity?

Cybin Announces Four Poster Presentations at the 2023 American College of Neuropsychopharmacology Annual Meeting Including CYB003 Phase 2 Topline Results

Business Wire

a year ago

Cybin Announces Four Poster Presentations at the 2023 American College of Neuropsychopharmacology Annual Meeting Including CYB003 Phase 2 Topline Results

Thomson Reuters StreetEvents

a year ago

Q3 2023 Duluth Holdings Inc Earnings Call

Duluth (DLTH) Q3 2023 Earnings Call Transcript

Motley Fool

a year ago

Duluth (DLTH) Q3 2023 Earnings Call Transcript

Matterport Signs Multi-Year Partnership with Vacasa to Provide Digital Twins for International Portfolio of Vacation Homes

GlobeNewswire

a year ago

Matterport Signs Multi-Year Partnership with Vacasa to Provide Digital Twins for International Portfolio of Vacation Homes

Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in Major Depressive Disorder with 79% of Patients in Remission after Two 12mg Doses

Business Wire

a year ago

Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in Major Depressive Disorder with 79% of Patients in Remission after Two 12mg Doses

Here's Why We're Watching Immuneering's (NASDAQ:IMRX) Cash Burn Situation

Simply Wall St.

a year ago

Here's Why We're Watching Immuneering's (NASDAQ:IMRX) Cash Burn Situation

Milestone Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

CNW Group

a year ago

Milestone Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

Milestone Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

PR Newswire

a year ago

Milestone Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

ParkOhio Announces Ratings Upgrade from Moody’s

Business Wire

a year ago

ParkOhio Announces Ratings Upgrade from Moody’s

Lifetime Brands, Inc. Announces the Completion of the Term Loan B Amendment and Extension

GlobeNewswire

a year ago

Lifetime Brands, Inc. Announces the Completion of the Term Loan B Amendment and Extension

Milestone Pharmaceuticals Third Quarter 2023 Earnings: US$0.45 loss per share (vs US$0.34 loss in 3Q 2022)

Simply Wall St.

a year ago

Milestone Pharmaceuticals Third Quarter 2023 Earnings: US$0.45 loss per share (vs US$0.34 loss in 3Q 2022)

Middlefield Banc Corp. Announces 2023 Fourth Quarter Cash Dividend Payment and Declares a $0.05 Special Cash Dividend Payment

GlobeNewswire

a year ago

Middlefield Banc Corp. Announces 2023 Fourth Quarter Cash Dividend Payment and Declares a $0.05 Special Cash Dividend Payment

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks

Insider Monkey

a year ago

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks

Associated Press Finance

a year ago

Milestone Pharmaceuticals: Q3 Earnings Snapshot

Sotera Health Appoints Karen Flynn to Board of Directors

GlobeNewswire

a year ago

Sotera Health Appoints Karen Flynn to Board of Directors

Milestone Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Clinical and Corporate Updates

CNW Group

a year ago

Milestone Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Clinical and Corporate Updates

HAMILTON BEACH BRANDS HOLDING COMPANY DECLARES QUARTERLY DIVIDEND AND ANNOUNCES STOCK REPURCHASE PROGRAM

PR Newswire

a year ago

HAMILTON BEACH BRANDS HOLDING COMPANY DECLARES QUARTERLY DIVIDEND AND ANNOUNCES STOCK REPURCHASE PROGRAM

Is AVROBIO (AVRO) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is AVROBIO (AVRO) Stock Outpacing Its Medical Peers This Year?

Associated Press Finance

a year ago

AG Mortgage Investment Trust: Q3 Earnings Snapshot

AG Mortgage Investment Trust, Inc. Reports Third Quarter 2023 Results

Business Wire

a year ago

AG Mortgage Investment Trust, Inc. Reports Third Quarter 2023 Results

Share on Social Networks: